ENLIVEX THERAPEUTICS
Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn's Disease, and other autoimmune and inflammatory disorders. The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and... facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity. Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
ENLIVEX THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2005-10-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.enlivex.com
Total Employee:
11+
Status:
Active
Contact:
+972-2-5722071
Email Addresses:
[email protected]
Total Funding:
75.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Sitelinks Search Box IPv6 Yoast WordPress SEO Plugin
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Enlivex Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Enlivex Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Enlivex Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - Enlivex Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Venture Round - Enlivex Therapeutics
HBL Hadasit Bio Holdings
HBL Hadasit Bio Holdings investment in Venture Round - Enlivex Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Series B - Enlivex Therapeutics
HBL Hadasit Bio Holdings
HBL Hadasit Bio Holdings investment in Series B - Enlivex Therapeutics
Shai Novik
Shai Novik investment in Debt Financing - Enlivex Therapeutics
Official Site Inspections
http://www.enlivex.com Semrush global rank: 2.3 M Semrush visits lastest month: 8.17 K
- Host name: vps58004.dreamhostps.com
- IP address: 173.236.141.184
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Enlivex Therapeutics"
Our Team - Enlivex
Our team Strong leadership, inspired by great science and a sense of mission. Our management, clinical advisors, personnel, and affiliates have extensive knowledge in the research and …See details»
About us - Enlivex
Enlivex was founded to advance the pioneering research of our co-founder, Professor Dror Mevorach, an expert in immune activity, macrophage …See details»
Enlivex Therapeutics - Crunchbase Company Profile & Funding
Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and …See details»
Enlivex Therapeutics (TLV:ENLV) Company Profile & Description
Mar 19, 2025 Enlivex Therapeutics Company Description Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy …See details»
Press Release Distribution and Management - GlobeNewswire
Ness-Ziona, Israel, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy …See details»
Enlivex - Org Chart, Teams, Culture & Jobs - The Org
Enlivex's mission is to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy. As a clinical-stage company focused on specialized cell …See details»
Enlivex Therapeutics - Overview, News & Similar companies
Jan 16, 2024 Enlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra™ In Patients With Sepsis Nes-Ziona, Israel, July 31, 2023 …See details»
Enlivex Therapeutics - Craft
Oct 28, 2024 Enlivex Therapeutics (previously known as Bioblast Pharma) is a clinical-stage company focused on specialized cell immunotherapy. It develops and commercializes an …See details»
Enlivex Therapeutics - Funding, Financials, Valuation & Investors
Enlivex Therapeutics is registered under the ticker NASDAQ:ENLV . Their stock opened with $12.25 in its Mar 27, 2019 IPO. Enlivex Therapeutics is funded by 4 investors. Israel …See details»
Enlivex Therapeutics 2025 Company Profile: Stock ... - PitchBook
Enlivex Therapeutics General Information Description. Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and …See details»
IR Overview - Enlivex
Nes-Ziona, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the "Company"), a clinical-stage macrophage reprogramming immunotherapy …See details»
Enlivex Therapeutics Ltd. (ENLV) - Yahoo Finance
Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which …See details»
Enlivex Therapeutics (Nasdaq: ENLV) - LinkedIn
Enlivex Therapeutics (Nasdaq: ENLV) | 1,492 followers on LinkedIn. Immune rebalancing | Our mission is to establish new equilibriums – both in patients’ immune responses and in the field …See details»
Corporate Governance - Enlivex
Investor relations Corporate governance. Our executive team has proven expertise in drug development, a strong track record of delivering shareholder value, and a dedicated focus on …See details»
Enlivex Therapeutics (ENLV) Stock Price & Overview - Stock Analysis
Mar 18, 2025 Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is …See details»
Enlivex Therapeutics Ltd. (ENLV) - Yahoo Finance
See the company profile for Enlivex Therapeutics Ltd. (ENLV) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Enlivex Issues Urgent Statement on Fraudulent News Dissemination
Feb 18, 2025 Enlivex is a clinical stage macrophage reprogramming immunotherapy company developing Allocetra™, a universal, off-the-shelf cell therapy designed to reprogram …See details»
Enlivex Therapeutics price target raised to $7 from $6 at H.C ...
2 days ago H.C. Wainwright raised the firm’s price target on Enlivex Therapeutics to $7 from $6 and keeps a Buy rating on the shares after the company announced that the China National …See details»
News Releases - Enlivex
Ness-Ziona, Israel, March 04, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the "Company"), a clinical-stage macrophage reprogramming immunotherapy …See details»
Our Science - Enlivex
Professor Dror Mevorach, Enlivex founder and executive scientific consultant, pioneered the research on the fate of dying (apoptotic) cells. "In the last 25 years, I have tried to understand …See details»